Handelsavisen
prelaunch
Companies ›Healthcare ›NSCI.V
NS
NSCI.V — TSX Venture Advanced Medical Equipment & Technology

Nsci.V

$0,12
Open in Charts → Attach watcher ⌖
— —
CAD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
17,3M CAD
P/E
—
EV / Rev
—
Div yield
—
Op margin
-14,1 %
ROE
-42,2 %
Net margin
-14,1 %
Debt / equity
1,31
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

NSCI.V operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment.

Business. NSCI.V operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target0,50

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
0,50
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
1 analysts · indicative
Ownership
—
not yet wired
Profitability→
-42,2 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning NSCI.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to NSCI.V. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    NSCI.V operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    NSCI.V has a market price of 0.135 CAD and a market cap of 18,691,334.69 CAD, with a price-to-book ratio of 1.39 and a price-to-tangible-book ratio of 1.39. The company's enterprise value to EBITDA is -6.39, indicating a negative EBITDA, and an enterprise value to revenue of 0.9. The company's liquidity is assessed as medium, with a current ratio of 0.97 and a debt-to-equity ratio of 1.31.

    The company's profitability is weak, with a return on equity of -0.4216 and a return on assets of -0.1473. The operating income is negative at -5,674,000 CAD, and the net income is also negative at -5,658,000 CAD. The company's gross profit is 9,964,000 CAD, but this is not sufficient to offset the operating losses.

    NSCI.V's revenue is concentrated in a single segment, with no disclosed geographic diversification. The company's operating cash flow is 3,452,000 CAD, but the free cash flow is negative at -4,115,000 CAD. The capital expenditure is -1,884,000 CAD, indicating a reduction in capital spending.

    The company's growth trajectory is uncertain, with no specific revenue growth projections provided. The company's total assets are 38,413,000 CAD, and total liabilities are 24,994,000 CAD, with long-term debt of 17,578,000 CAD. The company's total equity is 13,419,000 CAD.

    The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flags include a negative net cash position after subtracting total debt. The company's dilution potential is low, with no significant dilution sources identified.

    Recent events and filings do not provide specific details on the company's recent activities or strategic initiatives. The company's analyst estimates indicate a mean price target of 0.50 CAD, with a mean recommendation of 2.00 (1=strong buy, 5=strong sell). The number of strong-buy recommendations is 0, and the number of buy recommendations is 1.

    Key takeaways
    • NSCI.V has a negative operating income and net income, indicating financial distress.
    • The company's liquidity is medium, with a current ratio of 0.97 and a debt-to-equity ratio of 1.31.
    • The company's profitability is weak, with a return on equity of -0.4216 and a return on assets of -0.1473.
    • The company's revenue is concentrated in a single segment, with no geographic diversification.
    • The company's growth trajectory is uncertain, with no specific revenue growth projections provided.
    • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,12
    Market cap
    $18.7M
    Enterprise valueⓘ
    $36.3M
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    10.5x
    P / Bⓘ
    1.4x
    P / Tangible bookⓘ
    1.4x
    Tangible book
    $13.4M
    Net cashⓘ
    -$17.6M
    Current ratioⓘ
    1.0
    Debt / equityⓘ
    1.3
    ROAⓘ
    -14.7%
    ROEⓘ
    -42.2%
    Cash conversionⓘ
    -61.0%
    CapEx / revenueⓘ
    -4.7%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,00
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    —
    no estimate
    Segment revenue
    —
    no estimate
    Margin
    —
    no estimate
    Segment margin
    —
    no estimate
    as of 2026-05-04 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPS—no estimate—no estimate-0,00
    Revenue—no estimate—no estimate43,0M CAD
    Operating income—no estimate—no estimate1,9M CAD
    Full-year consensus mean (period as reported by source) · consensus in CAD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy1
    Hold0
    Sell0
    Strong sell0
    12-month price target$0,50 · Median $0,50
    Low $0,50High $0,50
    Operating income · consensus1,9M CAD
    EPS surprise
    −4 900,0 %
    reported vs consensus · miss
    Revenue surprise
    −6,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$0,50
    Mean$0,50
    Median$0,50
    High$0,50
    Spot$0,12
    +300.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-14,1 %Above median
    Net Margin-14,1 %Above median
    ROE-42,2 %Below median
    Capex / Rev-4,7 %Below median
    D/E1,31Bottom quartile
    Cash Conv-0,61Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • NSCI.V Market data — financials · 2026-05-28
    • Nanalysis Scientific Corp Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    2.2Kshares short+11.6% vs prior
    1days to cover
    23.6%short of daily vol
    2.5Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    NSCI.VCanonical
    TSX Venture · CAD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage